With Only One Product to Hope For, the Source of Downside Risks Are Numerous and Diverse; Analyst Report by BrokerBank Securities, Inc.
PR Newswire
NEW YORK, June 30, 2014
NEW YORK , June 30, 2014 /PRNewswire/ -- Titan Medical Inc. (OTCQX: TITXF) is a venture company with a market capitalization of about $200 million . Headquartered in Toronto , Canada. The company is involved in building a robotic surgical tool for application in minimally invasive surgery ("MIS"). The key concept of MIS is to minimize the incision area during the surgical operation. In general, MIS leads to quicker recovery, shorter hospital stays, less pain, fewer and smaller scars, reduced risk of infection, and less blood loss.
The notion of MIS has been around for many years and dozens of companies are already manufacturing surgical tools that meet the MIS definition. Titan is trying to capitalize on this opportunity of a bulging industry where national demographic changes and the ever increasing health service appetite/need makes the venture very appealing.
On June 16, 2014 , Titan released a statement saying it is on track in its building development schedule for its sole product SPORT Surgical System. SPORT Surgical System alpha commercial prototype phase has been completed on time (according to the management). The 35% increase in its share price from June 15 th to 28 th (9 trading days) could be attributed to this good news. Although such mile stone is monumental, Titan's future is dependent on many unknowns and known challenges.
Also, Titan has neither cutting edge nor marketing resources to be successful in the market. And unfortunately, it doesn't have any other alternative product as a plan B either. Sooner or later the market will realize the market position of Titan. Then any press release about success of marking the development milestones will have less lifting power for its share price.
A full in-depth analyst report on TITXF that includes risk factors, industry review, financial position, review of current business model, competition landscape, analyst summary, and recommendation can be viewed by using the following link at no cost:
http://bit.ly/-TITXF-Analyst-Report
Copy and paste to browser may be required.
FORWARD-LOOKING DISCLAIMER
This report may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of mentioned company to be materially different from the statements made herein.
COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort basis. This document, article or report is written and authored by Ujae Kang, Chartered Financial Analyst. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below. We do not engage in high frequency trading.
A full disclaimer can be found by viewing the full analyst report.
If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at editor@smallcaptraders.com . For any urgent concerns or inquiries please contact us at editor@smallcaptraders.com .
BrokerBank Securities, Inc. is a member of the Financial Industry Regulatory Authority, CRD number #130116.
SOURCE BrokerBank Securities, Inc.